European Medicines Agency's Management Board Nominates Guido Rasi as New Executive Director
The
Mr. Rasi has been Director-General of the Italian Medicines Agency since 2008, and member of the European Medicines Agency's Management Board since 2010.
Mr. Rasi holds a degree in medicine and surgery, with specialization in internal medicine, allergology, and clinical immunology from the University of Rome. From 1978 to 1990, Mr. Rasi worked as physician in hospital, research, and private practice. He worked from 1990 to 2008 in research at the Institute for Experimental Medicine of the National Research Council in Rome, directing the molecular medicine section from 2002 to 2005 and the Tor Vegata section from 2005 to 2008. He was made full professor of microbiology at the University of Rome (Tor Vegata) in 2008.
Andreas Pott will continue his role as Acting Executive Director until Guido Rasi takes office.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025